| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income (loss) | -294 | 137 |
| Depreciation and amortization | 87 | 59 |
| Net accretion of marketable securities | -317 | -214 |
| Share-based compensation | 103 | 68 |
| Noncash lease expense | 852 | 573 |
| Deferred income taxes | 139 | -3 |
| Inventories | -1,161 | -525 |
| Other current assets | -682 | -402 |
| Other assets | 601 | 334 |
| Accounts payable | 114 | 65 |
| Income taxes payable | -4,901 | -4,901 |
| Accrued commissions | -314 | -194 |
| Other accrued expenses | 44 | -110 |
| Deferred revenue | -422 | -311 |
| Amounts held in ewallets | -307 | -170 |
| Operating lease liabilities | -858 | -561 |
| Other current liabilities | -206 | -182 |
| Net cash used in operating activities | -5,038 | -5,151 |
| Purchases of property and equipment | 63 | 20 |
| Purchases of marketable securities | 39,011 | 27,552 |
| Proceeds from maturities of marketable securities | 51,619 | 34,215 |
| Net cash provided by (used in) investing activities | 12,545 | 6,643 |
| Dividends paid | 6,909 | 4,606 |
| Net cash used in financing activities | -6,909 | -4,606 |
| Effect of exchange rates on cash, cash equivalents and restricted cash | 206 | 118 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 804 | -2,996 |
| Cash and cash equivalents at beginning of period | 13,567 | - |
| Cash and cash equivalents at end of period | 14,371 | - |
NATURAL HEALTH TRENDS CORP (NHTC)
NATURAL HEALTH TRENDS CORP (NHTC)